Success Metrics

Completion Rate
0%(0/2)
Active Trials
0(0%)
Terminated
2(40%)

Phase Distribution

Ph phase_2
4
80%
Ph phase_3
1
20%

Phase Distribution

0

Early Stage

4

Mid Stage

1

Late Stage

Phase Distribution5 total trials
Phase 2Efficacy & side effects
4(80.0%)
Phase 3Large-scale testing
1(20.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 2 finished

Non-Completion Rate

100.0%

2 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Terminated(2)
Other(3)

Detailed Status

unknown3
Terminated2

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
0.0%
Most Advanced
Phase 3

Trials by Phase

Phase 24 (80.0%)
Phase 31 (20.0%)

Trials by Status

terminated240%
unknown360%

Recent Activity

0 active trials
Showing 5 of 5
unknownphase_2

SOX Combined With Sintilimab and Trastuzumab Versus SOX Regimen in the Perioperative Treatment of HER2-positive Locally Advanced Gastric Adenocarcinoma

NCT05218148
unknownphase_3

Compare S-1 Plus Oxaliplatin to S-1 as Adjuvant Chemotherapy After D2 Resection in Patients With Gastric Cancer

NCT01795027
terminatedphase_2

A Phase II Trial of Adjuvant Chemotherapy With S-1 Plus Oxaliplatin for Locally Advanced Gastric Cancer

NCT01946061
terminatedphase_2

SOX as Salvage Treatment in Nasopharyngeal Carcinoma

NCT01403259
unknownphase_2

Study of DPD for Predicting Efficacy and Safety to S-1 Plus Oxaliplatin in Gastrointestinal Cancer

NCT01608646

Clinical Trials (5)

Showing 5 of 5 trials
NCT05218148Phase 2

SOX Combined With Sintilimab and Trastuzumab Versus SOX Regimen in the Perioperative Treatment of HER2-positive Locally Advanced Gastric Adenocarcinoma

Unknown
NCT01795027Phase 3

Compare S-1 Plus Oxaliplatin to S-1 as Adjuvant Chemotherapy After D2 Resection in Patients With Gastric Cancer

Unknown
NCT01946061Phase 2

A Phase II Trial of Adjuvant Chemotherapy With S-1 Plus Oxaliplatin for Locally Advanced Gastric Cancer

Terminated
NCT01403259Phase 2

SOX as Salvage Treatment in Nasopharyngeal Carcinoma

Terminated
NCT01608646Phase 2

Study of DPD for Predicting Efficacy and Safety to S-1 Plus Oxaliplatin in Gastrointestinal Cancer

Unknown

All 5 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
5